In this blog post, we will walk you through what exactly lectins are, how they bind to glycans, why this process is important, how to understand this process, and many other insights to help you leverage lectins in your research.
Cancer remains one of the deadliest diseases in the world because we still haven’t fully comprehended why and how it occurs. This article will highlight some areas within cancer research utilizing glycobiology.
Glycobiology is a rapidly growing field that’s giving insights in a variety of research areas. Discover the role of glycobiology in diagnostics, therapeutics, and so much more in this article.
The parasitic sea lamprey has long remained the fishermen’s nightmare for harming fish in the Atlantic Ocean. However, their unique immune system could pave the way to substantial improvements in human glycome analysis. We review a study that demonstrates how lampreys generate antibodies that are specific for diverse glycans.
Pancreatic cancer is one of the deadliest cancers, especially when diagnosed at a later stage because of the lack of accurate biomarkers. Linking these biomarkers to cellular modifications is a promising approach to improve tumor evaluation. In this blog article, we review a study that explores the role of N-glycan modifications in pancreatic tumors.
Incorporating glycan analysis into your workflows is easier than you may think–especially when you use lectins, which are compatible with many commonly used lab assays. Join us as we walk through the key considerations to help you get started.
Lectins are essential in recognizing abnormal cell glycome and mediating tumor progression. That said, they can also be leveraged to enhance our knowledge of the glycome profiles of various cancers.
Why does glycobiology—the study of sugar chains—matter so much to our health? From the simplest to the most branched, carbohydrates are the key players in cellular functions—both healthy and pathological. This article summarizes the key elements of glycobiology in a nutshell.
Glycosylation networks have massive biomarker potential for breast cancer diagnosis and treatment. This study explores yet another alteration in breast cancer glycan profile: bisecting GlcNAc.